Clinical Implication of Multi-Genomic Analysis about Compound and Uncommon EGFR Mutations in the Non-small Cell Lung Cancer

被引：0
|
作者：
Lee, J. [1 ]
Kim, S. [1 ]
Kim, J. R. [2 ]
Sung, Y. E. [2 ]
Jung, C. K. [2 ]
Lee, G. J. [1 ]
Chun, S. H. [1 ]
Lee, Y. H. [3 ]
Kang, J. H. [2 ]
机构：
[1] Catholic Univ Korea, Bucheon St Marys Hosp, Coll Med, Bucheon, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul, South Korea
[3] Korea Basic Sci Inst KBSI, Res Ctr Bioconvergence Anal, Seoul, Chungcheongbuk, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Lung adenocarcinoma; epidermal growth factor receptor; mutation; Gene ontology;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.11-04
引用
收藏
页码：S205 / S206
页数：2
相关论文
共 50 条
  • [1] Multi-genomic analysis of compound and uncommon EGFR mutations in patients with non-small cell lung cancer.
    Park, Jayoung
    Lee, Yu Min
    Ka, Sojeong
    Kim, Seoree
    Kim, In-Ho
    Sung, Yeoun Eun
    Jung, Chan-Kwon
    Shin, Jung-Young
    Chun, Sang Hoon
    Lee, Young Ho
    Kang, Jin Hyoung
    Kim, Joori
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Real world data and multi-genomic analysis of non-common mutations in the EGFR mutation-positive non-small cell lung cancer
    Kim, Seoree
    Sung, Yeoun Eun
    Kim, Joo Ri
    Jung, Chan Kwon
    Kim, Jeong-Oh
    Shin, Jeong-Yeon
    Lee, Guk Jin
    Chun, Sang Hoon
    Lee, Young Ho
    Kang, Jin Hyoung
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Uncommon EGFR mutations in advanced non-small cell lung cancer
    O'Kane, Grainne M.
    Bradbury, Penelope A.
    Feld, Ronald
    Leighl, Natasha B.
    Liu, Geoffrey
    Pisters, Katherine -M.
    Kamel-Reid, Suzanne
    Tsao, Ming S.
    Shepherd, Frances A.
    LUNG CANCER, 2017, 109 : 137 - 144
  • [4] Current management of uncommon EGFR mutations in non-small cell lung cancer
    Trinh, Jonathan Q.
    Abughanimeh, Omar
    CURRENT PROBLEMS IN CANCER, 2024, 49
  • [5] Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence
    Attili, Ilaria
    Passaro, Antonio
    Pisapia, Pasquale
    Malapelle, Umberto
    de Marinis, Filippo
    CURRENT ONCOLOGY, 2022, 29 (01) : 255 - 266
  • [6] A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
    Tu, Hai-Yan
    Ke, E-E
    Yang, Jin-Ji
    Sun, Yue-Li
    Yan, Hong-Hong
    Zheng, Ming-Ying
    Bai, Xiao-Yan
    Wang, Zhen
    Su, Jian
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Dong, Zhong-Yi
    Wu, Si-Pei
    Jiang, Ben-Yuan
    Chen, Hua-Jun
    Wang, Bin-Chao
    Xu, Chong-Rui
    Zhou, Qing
    Mei, Ping
    Luo, Dong-Lan
    Zhong, Wen-zhao
    Yang, Xue-Ning
    Wu, Yi-Long
    LUNG CANCER, 2017, 114 : 96 - 102
  • [7] EGFR mutations in non-small cell lung cancer - Clinical implications
    Charpidou, Andriani
    Blatza, Despoina
    Anagnostou, Elsa
    Syrigos, Konstantinos N.
    IN VIVO, 2008, 22 (04): : 529 - 536
  • [8] The incidence of rare and compound mutations of EGFR in non-small cell lung cancer and their potential clinical significance
    Liang, Sharron
    Wang, Bin
    Chin, Venessa
    Huang, Min
    Wong, Stephen
    Riley, Denise
    Luo, Ruby
    Barrett, Wade
    Yang, Tao
    Qiu, Min Ru
    RESPIROLOGY, 2023, 28 : 28 - 29
  • [9] Uncommon EGFR Mutations in Non-Small Cell Lung Cancer: A Systematic Literature Review of Prevalence and Clinical Outcomes
    John, T.
    Taylor, A.
    Wang, H.
    Cripps, D.
    Eichinger, C.
    Freeman, C.
    Ahn, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S416 - S417
  • [10] Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis
    Wang, Chunsheng
    Zhao, Kewei
    Hu, Shanliang
    Dong, Wei
    Gong, Yan
    Xie, Conghua
    ONCOLOGIST, 2023, 28 (06): : E397 - E405
12345